Sofinnova Management X, L.L.C. 4
4 · CinCor Pharma, Inc. · Filed Aug 15, 2022
Insider Transaction Report
Form 4
Sofinnova Venture Partners X, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2022-08-11$30.00/sh+500,000$15,000,000→ 6,073,949 total(indirect: By Sofinnova Venture Partners X, L.P.)
Footnotes (1)
- [F1]The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X. Dr. James I. Healy and Dr. Maha Katabi are managing members of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. Each of SM X and Dr. Katabi disclaims beneficial ownership of such shares except to the extent of its or her respective pecuniary interest therein. Dr. Healy is a director of the Issuer and files separate Section 16 reports.